KIMBERLY HAVENS: Open Payments
NPI 1336713965 · VIERA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 21 payments from 10 companies in 2025. Trend: 2023 $334 · 2024 $505 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $138 |
| Otsuka America Pharmaceutical, Inc. | 2 | $64 |
| Calliditas Therapeutics US Inc. | 2 | $59 |
| Novo Nordisk Inc | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| GENZYME CORPORATION | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Vantive US Healthcare LLC | 1 | $18 |
Products named: ACTHAR, TARPEYO, VOYXACT, Ozempic, JYNARQUE, JARDIANCE, Fabhalta, CABLIVI.
Industry payments across FL — which companies pay providers there.
